Abstract |
The impact of prostate cancer (PCa) metastases on pelvic lymph nodes in local antitumor immunity remains unknown. We prospectively enrolled ten hormone therapy-naïve men undergoing salvage pelvic lymph node dissection (sPLND) and analyzed their peripheral blood (PB) and positive pelvic lymph nodes (PPLNs) with PCa metastases for tumor-reactive CD8+ T cells and myeloid-derived suppressor cells (MDSCs) using flow cytometry. MDSCs were stratified into CD14+ monocytic and CD14- granulocytic types. PD-L1/2 expression was also analyzed for MDSCs. Relative to PB, tumor-reactive CD8+ T cells accumulated in PPLNs (p<0.01) yet had decreased proliferation, with low Ki67 expression (p<0.05). Both CD14+ monocytic and CD14- granulocytic MDSCs were found in PPLNs, but there was an increase in the proportion of CD8+ T cells in PPLNs compared to PB (p<0.01). The granulocytic MDSCs exhibited a high degree of immunosuppressive activity (as evidenced by high pSTAT3 levels) and high levels of B7-H1 (PD-L1) and B7-DC (PD-L2) expression. Thus, granulocytic MDSCs probably suppress tumor-reactive CD8+ T-cells in PPLNs and exhibit high expression of immune checkpoint molecules in PCa nodal metastases. The data suggest a relative immunosuppressive state in PPLNs. This provides a biologic rationale for sPLND beyond just tumor debulking, and calls for further investigation of immune checkpoint blockade. PATIENT SUMMARY:
Prostate cancer metastases to lymph nodes may involve immunosuppressive cells that evade antitumor T-cells and create a relatively immunosuppressed state. This provides a rationale for treatment of such lymph nodes and/or for potential immunotherapy.
|
Authors | Vidit Sharma, Haidong Dong, Eugene Kwon, R Jeffrey Karnes |
Journal | European urology focus
(Eur Urol Focus)
Vol. 4
Issue 1
Pg. 75-79
(01 2018)
ISSN: 2405-4569 [Electronic] Netherlands |
PMID | 28753790
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Ki-67 Antigen
- MKI67 protein, human
|
Topics |
- Aged
- CD4-Positive T-Lymphocytes
(immunology)
- CD8-Positive T-Lymphocytes
(immunology)
- Flow Cytometry
(methods)
- Humans
- Immunotherapy
(methods)
- Ki-67 Antigen
(immunology)
- Lymph Node Excision
(methods)
- Lymph Nodes
(immunology, pathology, surgery)
- Male
- Middle Aged
- Myeloid-Derived Suppressor Cells
(immunology)
- Neoplasm Metastasis
- Prospective Studies
- Prostatic Neoplasms
(immunology, pathology, secondary, surgery)
- Salvage Therapy
(methods)
|